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Abstract.  The selectin family of adhesion molecules 
mediates the initial  interactions  of leukocytes with en- 
dothelium.  The extracellular region of each selectin 
contains an amino-terminal  C-type lectin domain,  fol- 
lowed by an EGF-like domain and multiple short con- 
sensus repeat units (SCR). Previous studies have in- 
directly suggested a role for each of the extracellular 
domains of the selectins in cell adhesion.  In this 
study, a panel of chimeric selectins created by ex- 
change of domains between L- and P-selectin was used 
to directly examine the role of the extracellular do- 
mains in cell adhesion.  Exchange of only the lectin 
domains between L- and P-selectin conferred the adhe- 
sive and ligand recognition functions of the lectin do- 
main of the parent molecule.  However, chimeric selec- 
tins which contained both the lectin domain of L-selec- 
tin and the EGF-like domain of P-selectin exhibited 
dual ligand-binding  specificity. These chimeric pro- 
teins supported adhesion both to myeloid cells and to 
high endothelial venules (HEV) of lymph nodes and 
mesenteric venules in vivo. Exchange of the SCR do- 
mains had no detectable effect on receptor function or 
specificity. Thus,  the EGF-like domain of P-selectin 
may play a direct role in ligand recognition and leuko- 
cyte adhesion mediated by P-selectin, with the lectin 
plus EGF-like domains collectively forming a func- 
tional ligand recognition unit. 
T 
HE selective recruitment of specific leukocyte subsets 
in a variety of normal and pathological  situations  is 
regulated principally  at the level of leukocyte-endothe- 
lial recognition.  The selectin  family of adhesion  molecules 
mediates the initial interactions  of leukocytes with endothe- 
lium which precedes leukocyte extravasation into tissues (8). 
The selectins have a unique and characteristic  domain struc- 
ture that  includes  an extracellular  C-type lectin  domain,  a 
single  EGF-like domain,  and between two and nine short 
consensus  repeat  (SCR)  1 units  homologous  to  domains 
found in complement-binding  proteins (10, 23, 33, 54, 60). 
The three selectins  (L-selectin,  E-selectin,  and P-selectin) 
are closely related  to each other in amino acid sequence, 
ranging  from  ~,40%  identity  in the SCR domains  up to 
~65 % in the lectin and EGF-like domains.  Although  each 
of these motifs can be found  in a variety  of proteins,  the 
selectins are the only example in which these three domains 
are found in immediate juxtaposition,  suggesting  that  this 
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optical density; SCR, short consensus repeat. 
spatial relationship  serves an important role in the function 
of this receptor family. 
Although  closdy related in structure,  the selectins  have 
distinct  patterns  of expression and  perform distinct  adhe- 
sive functions.  L-selectin is constitutively  expressed  on all 
classes of leukocytes and mediates  the binding  of lympho- 
cytes to the specialized high endothelial cells present in post- 
capillary venules (HEV) of lymph nodes, and leukocyte roll- 
ing on endothelium  at sites of tissue injury or inflammation 
(19, 35,  56,  61, 63,  65).  In contrast,  P-selectin  is rapidly 
mobilized to the surface of endothellum or activated platelets 
in response to agonists such as histamine or thrombin, and 
binds myeloid cells and a subset of T cells (7, 20, 29, 40). 
E-selectin is expressed primarily on endothelium  after acti- 
vation with proinflammatory cytokines, and also mediates 
adhesion of myeloid cells and a subset of memory T cells (9, 
37, 46,  48,  52).  The distinct  pattern of expression  of the 
selectins allows for control of both tissue specificity and the 
kinetics  of immune and inflammatory  responses. 
Previous studies on the molecular basis of adhesion medi- 
ated by selectins  have focused principally  on carbohydrate 
recognition by the lectin domains. Cell adhesion mediated by 
each of the selectins  can be blocked by certain  simple  or 
complex carbohydrates (22, 30, 58, 67), or by monoclonal 
antibodies (mAb) which define epitopes within the lectin do- 
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carbohydrates such as sLe  • have been identified as candi- 
date ligands for both P- and E-selectin (47, 50, 64). A heavily 
glycosylated  mucin-like protein, Glycam-1, that expresses an 
L-selectin  carbohydrate  ligand  has  been  identified  (32). 
These observations emphasize an important role for carbo- 
hydrate recognition in cell adhesion mediated by the lectin 
domain of selectins. 
The EGF-like and SCR domains of selectins may also play 
an important role in cell adhesion.  Deletion of either the 
EGF-like or SCR domains of L-selectin prevents recognition 
of ligands on HEV by a soluble form of the molecule (12, 
66).  Deletion of either the EGF-like or SCR domains of 
E-selectin abolishes or sharply reduces the ability of these 
receptors  expressed in COS  cells to mediate HL-60 cell 
binding (49).  Removal of these structural units may elimi- 
nate a ligand-binding component of the receptor or alterna- 
tively may alter the conformation of the remaining lectin do- 
main,  thereby accounting for reduced or absent receptor 
function. In addition,  adhesion-blocking mAb have been 
identified which define epitopes in the EGF-like domain of 
L-selectin (25, 53, 55) and in the SCR domains of L-selectin 
and E-selectin (24). Moreover, both EGF-like (4, 28, 69) and 
SCR (1, 2, 14, 27) domains present in a diverse array of pro- 
teins directly mediated protein-protein interactions. In spite 
of these observations, the role of the EGF-like and SCR do- 
mains in ligand recognition and cell adhesion by selectins re- 
mains essentially unknown. 
In this study, a domain swapping approach was used to 
identify the adhesive domains of L-selectin and P-selectin. 
In addition to confirming an important role for the lectin do- 
mains of these seleetins, the results provide evidence that the 
EGF-like domain of P-selectin also plays an important role 
in ligand recognition and cell adhesion. 
Materials and Methods 
Construction of Chimeric Selectin cDNA 
Chimeric selectin eDNA were constructed as described (25).  Restriction 
endonuclease cleavage sites were introduced by PCR-based site-directed 
mutngenesis into the L-selectin eDNA close to the borders between the lec- 
tin and EGF-likc domains (Psi I) and between the EGF-like and SCR do- 
mains (Sac 1) of L-selectin; these sites are naturally present in the P-selectin 
eDNA (23). Exchange of only the lectin domains at the Pst I site created 
the LPP and PLL eDNA, and exchange of the lectln plus EGF-like domains 
at the Sac I site created LLP and PPL (see Fig. D. Finally, replacement of 
the Pst I-Sac I segment of L-selectin, corresponding to the EGF-iike do- 
main of L-selectin, with the Pst I-Sac I segment of P-selectin, created LPL 
which contains only the EGF-like domain of P-selectin on a background of 
L-selection (see Fig. 1). A P-selectin eDNA lacking the lectin domain was 
generated by  tw~-step recombinant PCR  using  oligonucleotides which 
bridged the leader sequence and the EGF-like domain. The leader region 
up to the Tyr residue (residue number 4 as described in reference 23) was 
fused directly with amino acid residue 121  (Ser) at the beginning of the 
EGF-like domain. The cDNA was subcloned into pSP65 and sequenced to 
determine that the junctional border between the leader and EGF-like do- 
mains was intact and to verify that no spurious nocleotide substitutions oc- 
curred. These eDNA were all subcloned into the pMT-2 vector (26)  and 
used to transiently transfect COS cells by the DEAE-dextran method as de- 
scribed (25). 
Quantitative Analysis of Selectin Expression in 
Transfected COS cells 
Twenty-four hours before analysis, cDNA-transfeeted COS cells (2.5  x 
104/well) were replated into 96 well plates. Expression of specific epitopes 
by chimeric selectins was assessed using mAb reactive with specific do- 
mains and a surface immunofluorescence assay as described (38). Values 
given are means from triplicate wells of absolute optical density (OD) units 
from which mean OD unit values obtained with a control non-binding mAb 
were subtracted.  Standard deviations for triplicate determinations were 
<15%. Experimental values less than the control values are represented as 
zero. 
Selectin expression in transfected COS cells was also assessed by indirect 
immunofluorescence with flow cytometry analysis. Two days after transfec- 
tion, COS cells were removed from culture dishes by incubation in 2 mM 
EDTA at 370C  for 20 rain. Cells were incubated with mAb reactive with 
specific selectin domains (as ascites fluid diluted 1:200 or purified mAb at 
5  /~g/ml),  followed by FITC-conjugated rabbit antibodies reactive with 
mouse immunnglobulins. Analysis was performed on a Profile flow cytome- 
ter (Coulter Electronics, Hialeah, FL). 
COS Cell Adhesion Assays 
COS cells at "°50% conltuency were transfected with 3/~g of eDNA. One 
day after transfection, the COS cells were repla~l at '~50%  confluency 
onto 35-mm Primeria culture dishes (assay plates) (Becton-Dickinson, Lin- 
coin Park, NJ). The following day, HL-60 cells were washed twice in cold 
RPMI  1640  media (GIBCO  BRL,  Galthershurg,  MD),  resuspended in 
RPMI 1640  at a final concentration of 3.3  x  106 cells/ml, and 0.6 ml (2 
x  106 cells) was added to assay plates which had been washed twice with 
cold RPMI 1640 media. The plates were gently rocked for 20 min at 4°C, 
washed five times with cold RPMI medium and overlayered with RPMI con- 
taining 2%  (vol/vol) formalin. The number of HL-60 cells bound to in- 
dividnal COS cells were counted on a minimum of 100 COS cells. Where 
indicated, HL-60 cells were incubated in RPMI 1640 medium at 37°C for 
3 h with either 0.25 U/m1 Clostridium perfringens neuraminidase (Type VI, 
Sigma Chem.  Co.,  St.  Louis,  MO),  50  /~g/ml chymotrypsin or papaln 
(Sigma Chem. Co.), washed twice, and the assay was performed as de- 
scribed above. In some experiments, COS cells were preincubated with ei- 
ther 5 ~g/ml G1 mAb (Provided by Rodger McEver, Oklahoma Medical Re- 
search  Foundation,  Oklahoma  City,  OK),  which  is  directed  against 
P-selectin and which blocks P-selectin-mediated cell adhesion (20), or as- 
cites fluid containing the LAM1-3 mAb, which is a blocking mAb directed 
against the lectin domain of L-selectin (55), diluted 1:200. 
Construction of CeU Lines Stably Expressing Parental 
and Chimeric Selectins 
The eDNA encoding native L-selectin, LPP, and LPL were subeloned into 
the Barn HI site of  the pZIPneoSV(X) vector (15), and were used to transfect 
the mouse pre-B cell line 300.19  (3). Stable transfectants were selected in 
medium containing 0.5-1.0 mg/ml G418 (geneticin; Sigma Chem. Co.), and 
cells expressing the proteins were selected by panning with the LAM1-3 
mAb (55). To generate P-selectin transfectants, the P-selectin eDNA in the 
pMT-2 vector was cotransfected with the pSV2neo vector containing the 
neomycin resistance marker. 
lmmunoprecipitation Analysis 
Cells were surface labeled by the glucose/glucose oxidase/lactoperoxidase 
method. Immunoprecipitations were performed using anti-LAMI-3 mAb 
conjugated to Affigel (BioRad, Melville, NY) and analyzed by SDS-PAGE. 
HEV  Assays 
Rat lymph nodes were obtained from freshly euthanized Lewis rats, snap 
frozen in isopentane/liquid nitrogen, and stored at -70°C in isopentane un- 
til use. The HEV assay was as described (13).  Each cell type (5  x  106 
cells) was incubated on three 12 #m sections/slide at 64 rpm for 25 rain 
at ~4°C, the excess cells were gently removed, and the slides were placed 
vertically in ice-cold fixative (PBS/2.4%  glutaraldehyde) overnight. The 
slides were then counterstained with Gill's hematoxylin, overlaid with 
glycerol gelatin, and coverslips were applied. Each slide was scored for the 
number of test cells bound/HEV and 100-200 HEV were counted for each 
experiment. 
In Vivo Rolling Assays 
Rolling of 300.19  cells labeled with carboxyfluorescein diacetate (Sigma 
Chem. Co.), at 30/~g/ml in M199 medium, (GIBCO BRL) was investigated 
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as described (36). Through  an abdominal  midline incision, a small polyeth- 
ylene catheter was inserted retrogradely into the ileocecal artery. The ex- 
posed mesentery was superfused with a physiological  salt solution at low 
pO2 and observed through a Leitz intravital microscope (objective SW 
25/0.60) modified for telescopic imaging. Both rolling and freely flowing 
cells were observed with stroboscopic (50 s  -l,  Strobex 236, Chadwick 
Helmuth, Mountain View, CA) epifluorescence illumination (filter block 
Leitz I2) and recorded on video tape. The number of rolling fluorescent 
cells is expressed as leukocyte  flux, defined as the mean fraction  of injected 
leukocytes observed to be rolling in a given length of venule. 
Statistical Analysis 
Statistical analysis was performed by the two tailed Student's t test. 
Results 
Construction of Chimeric Selectins and Expression in 
COS Cells 
A  panel of chimeric selectins was constructed by exchange 
of the lectin, EGF-like, or both the lectin and EGF-like do- 
mains of L- and P-selectin (Fig.  1). These chimeric selectin 
cDNAs were used to transiently transfect COS cells. Expres- 
sion of these chimeric proteins at the surface of transfected 
COS cells  was confirmed and quantitated  using a  panel of 
domain-specific mAbs (Fig. 1). The level of  expression of  the 
chimeric selectins varied as a function of the composition of 
the hybrid molecules.  In general,  expression in transfected 
COS cells correlated with the 3' region of  the chimeric selec- 
tin  eDNA.  Thus,  LPP,  which  contains  the  lectin  domain 
from L-selectin and the EGF-like, SCR, transmembrane and 
cytoplasmic domains from P-selectin, and LLP, which con- 
tains both the lectin and EGF-like domains from L-selectin 
and the SCR and other domains from P-selectin, were each 
expressed at approximately the same level as parental P-selec- 
tin (Fig.  1).  Similarly, PLL, which contained the lectin do- 
main of P-selectin on a  background of L-selectin,  was ex- 
pressed at similar levels as PPL, which contained both the 
lectin  and  EGF-like  domains  from P-selectin  with the  re- 
mainder  of the  molecule  from  L-selectin.  Expression  of 
LPL, which contained only the EGF-like domain from P-selec- 
tin on a background of L-selectin, was equal to or lower than 
that of native L-selectin (Fig.  1). The level of expression of 
these molecules was independent of which EGF-like domain 
they contained. Evaluation of  the expression of  the eDNA by 
indirect immunofluorescence staining  with flow cytometry 
analysis correlated closely with the results  summarized  in 
Fig.  1,  with a  similar frequency of positively stained COS 
cells in each instance.  The appropriate expression of domain- 
specific epitopes within each domain of L- and P-selectin by 
these chimeric selectins demonstrated that the overall struc- 
ture of the hybrid proteins was intact, and suggests that do- 
main-specific  structural  features  were  retained  in  the  chi- 
meric proteins. 
Identification of  Functional Adhesive Domains 
of  P-selectin 
HL-60 cells express the P-selectin ligand(s) and were there- 
fore used in assays to identify adhesive domains of P-selectin 
(20, 29). Analysis of the binding of HL-60 cells to COS cells 
transfected with the eDNA encoding the chimeric selectins 
depicted in Fig. 1 revealed a specific, domain-dependent pat- 
tern of cell adhesion  (Fig.  2).  HL-60 cells bound to COS 
cells expressing P-selectin but not to COS cells expressing 
L-selectin  (Fig.  2  A).  These  results  demonstrate  that  al- 
though the lectin domain of recombinant soluble L-selectin 
appears to have a low but measurable affinity for sLe" (18), 
which is expressed on HL-60 cells and may form part of a 
ligand for P-selectin (16, 31, 42, 50), this interaction by itself 
Monoclonal antibody reactivity  Figure  1.  Structure  and  ex- 
G1  LAM1-3  LAM~-~  LAM~-~4  S~2  pression  of  L-selectin/P- 
(P  lectin)  (L lectin)  iL lectinlEGF)  (L SCR)  (P  SCR)  sele~tin  chimeric  proteins. 
0  525  374  576  0  Novel Pst I and Sac I restric- 
tion endonuclease  sites  were 
introduced into the L-selectin 
eDNA at the  indicated  10ca- 
1712  0  0  0  1059  tions,  allowing  for exchange 
of  the  lectin,  EGF-like 
839  0  68  419  0  (EGF), or both the lectin plus 
EGF-like domains with those 
of P-selectin.  The first  letter  714  0  0  350  0 
of  the  three  letter  designa- 
tions of the eDNA constructs 
19  1484  0  0  1093  corresponds to the eDNA en- 
coding the  lectin  domain  of 
0  1779  1503  0  101S  L-selectin  (L)  or  P-selectin 
(P), the second letter is for the 
0  363  0  266  0  EGF-Iike  domain  and  the 
third  letter  for the  $CR do- 
mains.  P-selectin domains are shaded,  and junctional boundaries at the introduced restriction  sites,  or at domain borders (as determined 
by the exon/intron  boundary of the gene) are drawn as vertical  lines.  TM, transmembrane domain; C, cytoplasmic domain. The double 
slanted  lines indicate  that all of the nine P-selectin  SCR domains are present, but are nut drawn.  Surface expression  of these selectins 
was analyzed by fluorescence ELISA as described in Materials  and Methods.  Experimental values less than the control values are repre- 
sented as zero. These data represent one of  four experiments  and similar results were obtained when the transfected COS cells were analyzed 
by flow cytometry. Note that the LAMI-1 mAb fails to recognize either the LPP or PLL proteins,  and therefore defines an epitope composed 
of residues  in both the lectin  and EGF domains. 
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Binding of HL-60 cells to transfected COS cells was performed at 
4°C, as described in Materials and Methods. (A) Binding of HL-60 
cells to COS cells transfected with parental and chimeric selectins. 
Original magnification, 200  x. The relative intensities of expres- 
sion of the recombinant proteins was similar to that represented in 
Fig. 1. (B) Mapping of P-selectin domain(s) responsible for adhe- 
sion of HL-60 cells. Bars represent the means + SD, and are repre- 
sentative of at least six experiments. 
was insufficient for any detectable cell adhesion in this sys- 
tem. HL-60 cells also bound to COS cells expressing PLL, 
which contained only the lectin domain from P-selectin (Fig. 
2 A). The lectin domain of P-selectin alone, when attached 
to the EGF-like and other domains of L-selectin, is therefore 
capable of mediating adhesion of HL-60 cells to transfected 
COS cells. 
Surprisingly, HL-60 cells also bound at high levels to COS 
cells expressing LPP, which contained the lectin domain of 
L-selectin attached to the EGF-like and  SCR domains of 
P-selectin (Fig. 2 A). This result suggests that in addition to 
the lectin domain, the EGF-like and/or the SCR domains of 
P-selectin could also mediate HL-60 cell adhesion. There- 
fore, the domain(s) within LPP responsible for HL-60 adhe- 
sion were mapped using additional chimeric selectins. HL- 
60 cells bound at high levels to COS cells expressing LPL 
(Fig. 2 B), which contained only the EGF-like domain from 
P-selectin, even though LPL was expressed at the lowest lev- 
els of any of the chimeric selectins in this study (Fig.  1). In 
contrast, HL-60 cells did not bind to COS cells expressing 
LLP (Fig.  2  B),  which contained only the SCR domains 
from P-selectin, and which was expressed at high levels (Fig. 
1). The adhesive activity within LPP is therefore within the 
EGF-like, not the SCR domains. Consistent with this, bind- 
ing of HL-60 cells to PPL, which contained both the lectin 
and EGF-like domains from P-selectin, was approximately 
equivalent to that of parental P-selectin and significantly (P 
<  0.01) higher than binding of HL-60 cells to PLL (Fig. 2 
B),  even though PLL and  PPL were expressed at nearly 
equal levels (Fig. 1). The EGF-like domain of P-selectin was 
therefore necessary for maximal adhesion of HL-60 cells to 
transfected COS cells. These results indicate that, in addition 
to the lectin domain, the EGF-like domain of P-selectin, but 
not the SCR domains,  can also play a  role in HL-60 cell 
adhesion. 
Role of the Lectin Domain in Adhesion Mediated by 
the P-selectin EGF-like Domain 
Lectin domain-mediated recognition of siaiic acid-contain- 
ing carbohydrates is an important component of P-selectin 
mediated cell adhesion (16, 42, 50, 68). The contribution of 
the lectin domain to the adhesion mediated by P-selectin and 
these chimeric selectins was therefore examined. Neuramin- 
idase treatment completely removed the sLe  x tetrasaccha- 
ride from the surface of HL-60 cells as determined using the 
CSLEX1 mAb in indirect immunofluorescence staining with 
flow cytometry analysis (data not shown).  However, neu- 
roaminidase treatment inhibited only 60-70 % of the binding 
of HL-60 cells to COS cells expressing native P-selectin or 
PPL which contained both the lectin and EGF-like domains 
from P-selectin (Fig. 3). In contrast, pretreatment of HL-60 
cells with neuraminidase inhibited >95 % of the adhesion 
mediated by PLL, which contained only the lectin domain 
from P-selectin (Fig. 3). Pretreatment of cDNA-transfected 
COS cells with the G1 mAb directed against the lectin do- 
main of P-selectin (Fig.  1) inhibited HL-60 cell adhesion to 
COS cells in a similar manner. HL-60 adhesion to COS cells 
expressing P-selectin or PPL was inhibited by only ,,o70% 
(Fig. 3), while HL-60 adhesion to COS cells expressing PLL 
was inhibited by >95 % (Fig.  3). 
The role of the L-selectin lectin domain in HL-60 cell 
adhesion mediated by LPL was similarly examined. Interest- 
ingly, neuraminidase treatment of the HL-60 ceils inhibited 
50-60% of the adhesion mediated by LPL (Fig. 3 A), as did 
pretreatment of LPL-expressing COS  ceils with  LAM1-3 
mAb, which recognizes the L-selectin lectin domain (25). 
These results closely parallel the results described above and 
indicate that the lectin domain of L-selectin present in LPL 
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main and specificity of adhe- 
sion  mediated  by  chimeric 
selectins. Assessment of HL- 
60 cell attachment to eDNA- 
transfected  COS  cells  after 
various treatments. (A) HL-60 
cells  were  treated  with 
medium or neuraminidase, or 
the  COS  cells  were  prein- 
cubated  with  the  G1  mAb 
directed against the lectin do- 
main  of  P-selectin  or  the 
LAM1-3 mAb directed against 
the lectin domain of L-selec- 
tin.  Values obtained  using 
isotype-matched control mAb 
were similar to those obtained 
using cells treated with media 
alone. (B) HL-60 cells were treated with medium, chymotrypsin, or papain. Adhesion assays were performed as described in Materials 
and Methods. Bars represent the means  +  SD, and results represent one of at least four independent experiments. 
mediates a portion of the adhesion mediated by LPL. HL-60 
cell adhesion mediated by chimeric selectins which included 
the P-selectin EGF-like domain was therefore partially resis- 
tant to elimination of lectin domain activity. In addition, al- 
though recognition of carbohydrates on HL-60 cells by the 
lectin domain of L-selectin was not sufficient for cell adhe- 
sion (Fig.  2 A),  this interaction appeared to contribute to 
HL-60 cell adhesion when the EGF-like domain of  P-selectin 
was  also  present  (Fig.  3  A).  Similarly,  removal of Ca  ~ 
from the assay medium with 2.5 mM EGTA abolished HL- 
60 attachment in all cases (data not shown). Thus, in addi- 
tion to the Ca++-dependent  lectin domain-carbohydrate in- 
teraction, the EGF-mediated interactions may also be Ca  ++ 
dependent. 
Adhesion mediated by P-selectin is sensitive to protease 
treatment of ligand-bearing cells (31, 41, 42), while adhesion 
mediated by E-selectin is resistant to proteases (31). There- 
fore, HL-60 cells were treated with protease to determine 
whether the  production of chimeric  selectins  altered  the 
ligand-binding  activity of P-selectin.  Treatment of HL-60 
cells with chymotrypsin sharply reduced adhesion mediated 
by constructs containing both the leetin and/or EGF-like do- 
mains  of P-selectin,  and  treatment  with  papain  inhibited 
adhesion by >90% (Fig. 3 B). Binding mediated by the lectin 
domain and/or the EGF-like domains of P-selectin is there- 
fore protein dependent,  consistent with the existence of a 
protein ligand. 
P-selectin lacking the lectin domain was expressed oi  the 
surface of COS cells and assessed for its ability to mediate 
HL-60 cell adhesion. The portion of the P-seleetin eDNA 
encoding the lectin domain was deleted, leaving the amino- 
terminal leader sequence fused directly with the EGF-like 
domain. This eDNA produced a cell surface protein in COS 
cells that was readily identified in immunofluorescence as- 
says by mAb which bind to the SCR domains of P-selectin, 
but not by mAb which bind to the lectin domain. Although 
this molecule was expressed on the cell surface at levels simi- 
lar to LPP and LLP, it was not capable of mediating HL-60 
cell attachment (data not shown). 
Analysis of  Functional Domains of  L-selectin 
It is possible that introduction of the P-selectin EGF-like do- 
main  into  L-selectin changed  the  conformation or  other 
properties of the L-selectin lectin domain. This could con- 
ceivably cause such chimeric selectins to bind HL-60 cells 
through this putatively altered lectin domain,  rather than 
directly through the EGF-like domain. To address this issue, 
it was essential to determine if the L-selectin lectin domain 
present in LPP and LPL retained the ability to recognize its 
natural ligands. Towards this end, cell lines stably expressing 
LPP, LPL, L-selectin, or P-selectin were produced using a 
murine cell line which does not express L-selectin. The pa- 
rental and chimeric selectins were expressed at similar levels 
on the surface of the transfected cell lines, with only a '~3- 
fold  difference between  the  mean  fluorescence levels  of 
L-selectin and P-selectin transfectants (Fig. 4 A).  In addi- 
tion, the transfected gene products exhibited the appropriate 
mobility with SDS-PAGE analysis (Fig. 4 B). L-selectin iso- 
lated from human lymphocytes has a  Mr of 74,000 while 
L-selectin from mouse lymphocytes has a  Mr of '~90,000 
due to differences in posttranslational processing. P-selectin 
isolated from human platelets has a Mr of 140,000.  There- 
fore, the chimeric human proteins expressed in mouse cells 
are appropriately sized. 
Transfected cells expressing L-selectin, P-selectin, LPP, 
or LPL were examined for their ability to bind to lymph node 
HEV in the Stamper-Woodruff  frozen section assay (57). Un- 
transfeeted cells or cells expressing P-selectin did not bind 
at significant levels (Table I).  In contrast, cells expressing 
L-selectin, LPP or LPL, all of which contain the L-selectin 
lectin domain, bound to HEV equivalently and at high levels. 
Cell binding to HEV was completely blocked by LAM1-3 
mAb (Table I), which is directed against the lectin domain 
of L-selectin (25). Therefore, the lectin domain from L-selec- 
tin alone,  on a  background of P-selectin,  was  capable of 
mediating the HEV-binding properties of L-selectin. 
Since  L-selectin also  mediates  leukocyte roiling  along 
postcapillary venules at sites of  tissue injury or inflammation 
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tins in transfected 300.19 cells. 
(A)  Flow  cytometry analysis 
of cell  surface expression of 
cDNA-transfected  300.19 cells 
stably  expressing  L-selectin, 
P-selectin, LPP, or LPL. Re- 
suits  are depicted on a  three 
decade logarithmic scale. The 
filled  in histograms represent 
background staining obtained 
with  a  nonbinding  negative 
control mAb of the same iso- 
type.  (B)  Immunoprecipita- 
tion and  SDS-PAGE  analysis 
of natural and chimeric selec- 
tins  from  stably  transfected 
300.19 ceils that were surface 
labeled  with  125I. Molecular 
weight standards (in kD) are in- 
dicated  and  the  gel  was  run 
under  reducing  conditions. 
P selectin contains nine SCR 
domains  and  L-selectin  con- 
tains  two,  accounting  for the 
size differences in the chimeric 
proteins. 
(35,  36,  62),  the ability  of cells  transfected  with  chimeric 
selectins  to  roll  in  vivo  was  examined.  Untransfected  or 
P-selectin-transfected  cells did not roll at detectable  levels. 
Similar  to  the  results  in  the  HEV-binding  assay,  cells  ex- 
pressing L-selectin,  LPP,  or LPL exhibited  significant and 
equivalent rolling in vivo in postcapillary venules of the ex- 
teriorized  rat  mesentery  (Fig.  5).  As  with  HEV  binding, 
mAb directed against the lectin domain of L-selectin corn- 
pletely blocked rolling,  confirming  the activity of this  do- 
main  in  adhesion.  These  data  demonstrate  that  the  spec- 
ificity and function of the L-selectin lectin domain present 
in LPP and LPL were preserved. The LPP and LPL chimeric 
selectins therefore exhibited a dual ligand recognition spec- 
ificity, binding to both HL-60 cells bearing P-selectin ligands 
and to L-selectin ligands present on lymph node HEV and 
mesenteric  endothelium. 
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cDNA  LAM1-3  mAb  expt 1  expt 2  expt 3 
None  -  0.047  +  0.02  0.12  +  0.025  <0.01 
+  <0.01  ND  ND 
L-selectin  -  3.43  5-  0.42  6.85  +  0.45  2.44  +  0.51 
+  0.05  5-  0.2  ND  <0.01 
LPP  -  3.71  ±  0.26  6.64  +  0.43  4.40  +  0.3 
+  0.074  +  0.03  ND  <0.01 
LPL  -  5.71  +  0.33  6.85  +  0.18  3.94  +  0.27 
+  0.08  +  0.03  ND  <0.01 
P-selectin  -  <0.01  <0.01  ND 
Transfected  mouse 300.19 ceils were prepared and HEV assays were performed as described in Materials and Methods.  LAM1-3  mAb was used as ascites fluid 
diluted 1:200.  Data are presented as the mean +  SD of cells bound/HEV from >100 HEV examined for three independent  experiments. Similar results were oh- 
mined in three additional experiments. Values obtained using an isotype-matched  control mAb were similar  to those obtained using cells treated with media alone. 
The variation seen in the levels of binding is typical for these assays. ND,  not determined. 
Discussion 
The functional analysis of chimeric proteins produced by ex- 
change of homologous segments between members of the 
same gene family has proven to be a powerful approach to- 
wards  identifying the  functions  of specific domains  and 
amino acid residues in a diverse array of biological systems. 
The advantage of such an approach is that the overall second- 
ary and tertiary structure of the hybrid proteins is main- 
tained, while the potential problems associated with deletion 
mutants  such as gross alterations of structure,  expression 
and function are avoided. This approach was applied to the 
identification of adhesive domains of L- and P-selectin. The 
most striking and important conclusion from these studies 
is that the EGF-like domain of P-selectin is involved in ligand 
recognition and  cell  adhesion.  Chimeric  selectins  which 
20 
•  no  mAb 






none  L-selectin  LPP  LPL 
cDNA 
Figure 5. The lectin domain of L-selectin mediates leukocyte roll- 
ing in mesenteric venules. 300.19 cells stably transfected with the 
indicated cDNA were tested for their ability to roll in vivo in exteri- 
orized venules of  the rat mesentery. Results obtained using isotype- 
matched control mAb were similar to those obtained using cells 
treated with media alone as described (36). 
contained both the lectin domain from L-selectin and the 
EGF-like  domain  from  P-selectin  exhibited the  adhesive 
properties of both L-selectin and P-selectin: LPP and LPL 
mediated binding of HL-60 cells, a property of P-selectin but 
not L-selectin, and also mediated cell binding to lymph node 
HEV and mesenteric venules, a characteristic of L-selectin 
but not P-selectin. The LPL chimeric selectin which con- 
tained only the EGF-like domain of P-selectin on a back- 
ground of L-selectin bound HL-60 cells (Fig.  2  B) even 
though it was  expressed at the lowest level of any of the 
cDNA constructs used in this study (Fig.  1). Most impor- 
tantly, each of the chimeric selectins which contained the 
EGF-like domain from P-selectin supported significant lev- 
els of HL-60 cell adhesion that was partially resistant to 
blocking by lectin domain-specific mAb or neuraminldase 
treatment of HL-60 cells (Fig. 3). Each of these treatments 
completely eliminated adhesion mediated by the lectin do- 
main of P-selectin (Fig. 3; PLL) or L-selectin (Table I). The 
dual specificity of these chimeric L- and P-selectins consti- 
tutes direct and powerful evidence that the EGF-like domain 
of  P-selectin  participates  in  ligand  recognition  and  cell 
adhesion. 
Two  mechanisms  by  which  the  EGF-like  domain  of 
P-selectin participates  in  ligand  recognition are possible, 
both are novel and of major significance. First, placement of 
the P-selectin EGF-like domain next to the L-selectin lectin 
domain may induce a change in the conformation of the ad- 
joining  L-selectin lectin domain resulting in a  change in 
affinity or in the acquisition of a novel carbohydrate ligand 
recognition capability. Second, the P-selectin EGF-like do- 
main may participate directly in ligand recognition via pro- 
tein-protein interactions. The results of this study support 
the second mechanism. Juxtaposition of the lectin domain of 
either L- or P-selectin with the EGF-like domain of  the other 
selectin did not appear to affect the specificity or adhesive 
activity of the lectin domains for their known physiologic 
ligands (Figs. 2 and 6, Table I). Both L-selectin and LPP bind 
PPME, a complex polysaccharide which specifically blocks 
L-selectin-dependent binding of lymphocytes to HEV, while 
P-selectin exhibits no binding activity for PPME (25). The 
overall structure of the  L-selectin lectin domain was  not 
significantly altered by juxtaposition with the EGF-like do- 
main of P-selectin in that seven mAb-defined epitopes lo- 
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chimeric proteins (55). Also, LPP, which contained only the 
lectin domain from L-selectin, mediated adhesion to HEV 
and rolling as well as native L-selectin (Fig. 5), even though 
it was expressed at twofold lower levels (Fig.  1). Similarly, 
PLL expressed by transfected COS cells mediated HL-60 
cell adhesion at significant levels (Fig. 2). Thus, the activi- 
ties and specificities of the lectin domains were not dramati- 
cally altered in these chimeric selectins. 
Direct protein-protein interactions mediated by the EGF- 
like domain of P-selectin are suggested by the ability of na- 
tive P-selectin and chimeric (PPL and LPL) selectins con- 
taining the P-selectin EGF-like domain to support significant 
levels of HL-60 binding in the absence of lectin domain ac- 
tivity (Fig. 3 A). Additionally, HL-60 cell adhesion mediated 
by PLL expressed by transfected COS cells was only •70  % 
of that mediated by PPL (Figs.  2 and 3), even though these 
two chimeric selectins were expressed at nearly identical lev- 
els (Fig. 1), Furthermore, only a portion of HL-60 binding 
by LPL was blocked by abrogating L-selectin lectin domain 
function (Fig. 3 A). This suggests that the L-selectin lectin 
domain in this construct is mediating a portion of the adhe- 
sion,  even though no adhesion was observed with native 
L-selectin (Fig. 2) which was expressed at the same or higher 
levels (Fig. 1). A likely explanation for these observations is 
that the L-selectin lectin domain may naturally bind sLe  x or 
other carbohydrates on the  HL-60 cell surface with low 
affinity. This binding alone does not support cell adhesion 
(Fig. 2), but is sufficient for cell adhesion when this interac- 
tion is supported by the adhesive activity of an adjoining 
P-selectin EGF-like domain. While the finding that deletion 
of the lectin domain from P-selectin resulted in the concomi- 
tant loss of ligand-binding activity argues against a direct 
ligand-binding activity for the EGF-like domain, it is possi- 
ble that deletion of  the proximal lectin domain affects the ter- 
tiary structure of the EGF-like domain, thereby inhibiting 
ligand-binding activity. Nonetheless, the results of this study 
suggest an important role for the EGF-like domain for maxi- 
mal P-selectin-mediated cell adhesion. 
The EGF-like domain of L-selectin does not appear to be 
required for maximal adhesion since LPL and LPP have 
functional activities similar to L-selectin (Fig. 5, Table I). 
Therefore, the adhesive function of the EGF-like domain of 
P-selectin may be unique to this selectin. This is also consis- 
tent with the strikingly higher degree of amino acid sequence 
conservation of the EGF-like domain in P-selectin between 
human, mouse, and cow (89% identical) compared with ei- 
ther E-selectin (58%) or L-selectin (69%) (6, 10, 11, 23, 33, 
51, 59, 60). Dual recognition by P-selectin of  both a carbohy- 
drate and a protein ligand would define a cellular interaction 
of higher affinity and specificity than recognition mediated 
by the lectin domain alone. The P-selectin EGF-like domain 
may mediate protein-protein interactions in a manner simi- 
lar to thrombomodulin EGF-like domains which bind throm- 
bin (28, 69), and plasminogen activator where the EGF-like 
domain contains the ligand-binding site (4). The cooperative 
action of two adhesive domains may explain the ability of 
P-selectin  to  mediate  intercellular adhesion  even  though 
there are only low levels of P-selectin expressed on the sur- 
face  of activated platelets  and  endothelium  (*50  mole- 
cules//zm  2)  (21,  39,  40).  This  model would also  explain 
why the  carbohydrate recognition  capabilities  of E-  and 
P-selectin appear to be either closely overlapping or identical 
(31,  50,  68),  while the  observed  molecular  and  cellular 
ligand specifieities are distinct (5,  17, 31, 34, 42). 
This study did not reveal a direct role for the SCR domains 
of L- or P-selectin in cell adhesion. The reciprocal exchange 
of nine P-selectin SCR domains for two L-selectin SCR do- 
mains had no detectable effect on ligand binding. Further- 
more, these results suggest that no stringent requirement ex- 
ists for any particular number of SCR. This is consistent with 
the variable number of SCR found in both P-selectin and 
E-selectin of different animal species. In addition, the levels 
of homology found between SCR domains of different selec- 
tins and among different species are lower than for the other 
extracellular domains. However,  certain structural features 
of selectin SCR domains may be required for function since 
deletion of  the SCR domains from E-selectin sharply impairs 
cell adhesion, and deletion of  the SCR domains from soluble 
forms of L-selectin impairs carbohydrate recognition by the 
lectin domain (49, 66). Thus, the SCR domains may contrib- 
ute indirectly to lectin domain function, perhaps by stabiliz- 
ing receptor structure or oligomerization. 
In summary, the results presented here indicate that both 
the lectin and the EGF-like domains of P-selectin are directly 
involved in cell adhesion.  Furthermore,  the dual ligand- 
binding specificity of the chimeric selectins described in this 
report may also be clinically useful in blocking selectin func- 
tion and consequent inflammation and tissue damage in set- 
tings where multiple selectins are involved. In this regard, 
acute lung injury in rats induced by infusion of cobra venom 
factor depends in part on P-selectin and in part on L-selectin 
(43, 45); similarly, IgG-immune complex mediated disease 
is dependent on both E-selectin and L-selectln (44, 45). In 
each case, inhibitory reagents directed against only a single 
selectin give only partial protection (43-45).  Soluble pro- 
teins derived from chimeric selectins with dual specificity 
may therefore be potent inhibitors of leukocyte-mediated  tis- 
sue damage. 
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